Proteasome inhibitor VR23, Purity ≥98%

Cat. No.: X24-07-ZQ769

Proteasome inhibitor VR23, Purity ≥98%

Synonym: 1624602-30-7; Proteasome inhibitor; VR-23; VR 23

  • MDL: MFCD28502093
  • CAS Number: 1624602-30-7
  • Compound CID: 73442847
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
VR23, soluble in warmed DMSO and warmed water and insoluble in ethanol, interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma. It targets Caspase-like proteasomes, Chymotrypsin-like proteasomes, and trypsin-like proteasomes.
Molecular Weight
477.88
Molecular Formula
C19H16ClN5O6S
Targets
Caspase-like proteasomes: 3 μM; Chymotrypsin-like proteasomes: 50-100 nM; Trypsin-like proteasomes: 1 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 29 mg/mL (60.68 mM); Warmed water: 5 mg/mL (10.46 mM); Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
VR23 is used in research to investigate and inhibit proteasome activity, which is key in regulating protein degradation and cellular processes.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0